Interestingly, in lower-grade astrocytomas with IDH1 mutations, higher GLUD1 and GPT2 expression correlates with lower GSH levels, potentially increasing sensitivity to oxidative stress and treatments like radiation therapy [137]. The gene discussed is GLUD1; the disease is astrocytoma (excluding glioblastoma).